Wockhardt Shares Jump 11% After CDSCO Approves New Antibiotic
Shares of Wockhardt Limited hit a day high of Rs 1,974.00 on NSE on 29 May, surging as much as 11.5% intraday, after India’s drug...
Tag : Wockhardt ltd
Wockhardt’s Foviscu Meets Phase 3 Endpoint; Stock Trades Flat
Shares of Wockhardt Ltd are trading flat after touching a day’s high of Rs 1,411.90 on 27th January. This comes despite the firm announcing that...
Wockhardt Jumps 5% as Zaynich shows success against pan-drug resistant infection
Shares of Wockhardt Ltd surged 5% to touch a day’s high of Rs 1,775 on 28th July, after the company stated a medical case where...
Wockhardt Shares Gain 3.5% on Exit from Loss-Making US Generics Business
Shares of Wockhardt Ltd rose 3.5% to touch a day’s high of Rs 1,854 on 14th July, after the company announced its exit from the...
Wockhardt Shares Hit 10% Upper Circuit as Zaynich Achieves 96.8% Efficacy
Shares of Wockhardt Ltd hit 10% upper circuit on 31 January after the company’s widely used discovery medication Zaynich showed 96.8% efficacy in a Phase...
Wockhardt Shares Soar 4% as Zaynich Shows 97% Clinical Efficacy
Shares of Wockhardt Ltd soared 4% on 13 January after the company’s drug Zaynich showed clinical efficacy of over 97% in treating critically ill patients...
Wockhardt Shares Skyrocketed 9% on Receiving Approval for Pneumonia Antibiotic
Shares of Wockhardt Ltd skyrocketed 9% on 3 January after the Indian pharma authority approved an oral antibiotic for the treatment of pneumonia. The Central...
Wockhardt Submits Fast-Acting Insulin to DCGI, Shares Jump 4%
Shares of Wockhardt Ltd. surged 4%, reaching a day’s high of Rs 1,126.50 on 16th October, after the company announced it had filed its fast-acting...
Wockhardt Shares Hit Upper Circuit as Investigational Drug Cures Meningitis, Up 5%
Shares of Wockhardt Ltd. rallied 5% to hit an upper circuit at Rs 1,005.70 on 19th September, after the company announced that its investigational drug,...
Wockhardt Looking to Complete Phase III Trials for Zaynich
The Indian pharma company, Wockhardt Ltd, on Wednesday, 29 May, said that the Phase III clinical trial for Zaynich (Zidebactam/Cefepime) is expected to be completed...